Leadership Team Our leadership team is comprised of seasoned executives with track records translating scientific discoveries into successful global drug approvals. Desmond Padhi, Pharm.D.Interim Chief Executive OfficerRead more →Bryan Moyer, Ph.D.Senior Vice President, DiscoveryRead more →Holly Carlisle, Ph.D.Vice President, Translational ScienceRead more →Mike Kaufman, Ph.D.Vice President, ChemistryRead more →Board of DirectorsNancy Stagliano, Ph.D.Chair, Board of DirectorsRead more →Hyung Chun, M.D.Director, Foresite CapitalRead more →Sean Harper, M.D.Co-Founding Managing Director, Westlake Village BioPartnersRead more →Deborah Palestrant, Ph.D., M.B.A.Partner, 5AM Ventures and Executive Chair, 4:59 InitiativeRead more →Desmond Padhi, Pharm.D.Interim Chief Executive OfficerRead more →Nicholas A. Saccomano Ph.D.Chief Executive Officer, OnKure TherapeuticsRead more →
